Class information for:
Level 1: INTERNATIONAL SENSITIVITY INDEX//PROTHROMBIN TIME//INTERNATIONAL NORMALIZED RATIO

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
6306 1436 24.7 66%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1107 9272 WARFARIN//CYP2C9//VKORC1

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTERNATIONAL SENSITIVITY INDEX Author keyword 106 100% 2% 31
2 PROTHROMBIN TIME Author keyword 72 34% 12% 173
3 INTERNATIONAL NORMALIZED RATIO Author keyword 60 35% 10% 140
4 ECAA CENT IL Address 33 100% 1% 13
5 INR Author keyword 32 30% 6% 90
6 ECAA Address 26 100% 1% 11
7 INTERNATIONAL NORMALISED RATIO Author keyword 25 58% 2% 28
8 EAA CENT IL Address 23 100% 1% 10
9 ORAL ANTICOAGULANT CONTROL Author keyword 17 100% 1% 8
10 PATIENT SELF TESTING Author keyword 17 75% 1% 12

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 INTERNATIONAL SENSITIVITY INDEX 106 100% 2% 31 Search INTERNATIONAL+SENSITIVITY+INDEX Search INTERNATIONAL+SENSITIVITY+INDEX
2 PROTHROMBIN TIME 72 34% 12% 173 Search PROTHROMBIN+TIME Search PROTHROMBIN+TIME
3 INTERNATIONAL NORMALIZED RATIO 60 35% 10% 140 Search INTERNATIONAL+NORMALIZED+RATIO Search INTERNATIONAL+NORMALIZED+RATIO
4 INR 32 30% 6% 90 Search INR Search INR
5 INTERNATIONAL NORMALISED RATIO 25 58% 2% 28 Search INTERNATIONAL+NORMALISED+RATIO Search INTERNATIONAL+NORMALISED+RATIO
6 ORAL ANTICOAGULANT CONTROL 17 100% 1% 8 Search ORAL+ANTICOAGULANT+CONTROL Search ORAL+ANTICOAGULANT+CONTROL
7 PATIENT SELF TESTING 17 75% 1% 12 Search PATIENT+SELF+TESTING Search PATIENT+SELF+TESTING
8 ANTICOAGULATION CLINIC 15 62% 1% 16 Search ANTICOAGULATION+CLINIC Search ANTICOAGULATION+CLINIC
9 ORAL ANTICOAGULATION 13 18% 5% 67 Search ORAL+ANTICOAGULATION Search ORAL+ANTICOAGULATION
10 THROMBOPLASTIN 13 28% 3% 38 Search THROMBOPLASTIN Search THROMBOPLASTIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PROTHROMBIN TIME 83 34% 14% 197
2 LYOPHILIZED PLASMAS 79 94% 2% 29
3 PROTHROMBIN TIME MONITOR 62 90% 2% 27
4 THROMBOPLASTIN 47 44% 6% 80
5 SENSITIVITY INDEX ISI 41 90% 1% 18
6 INTERNATIONAL NORMALIZED RATIO 40 22% 11% 160
7 INR 39 49% 4% 59
8 PLASMA CALIBRANTS 38 93% 1% 14
9 THROMBOPLASTIN REAGENTS 34 93% 1% 13
10 COAGUCHEK XS 33 100% 1% 13

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Pharmacology and management of the vitamin K antagonists 2008 794 318 31%
Meta-analysis: Effect of Patient Self-testing and Self-management of Long-Term Anticoagulation on Major Clinical Outcomes 2011 55 43 67%
Managing oral anticoagulant therapy 2001 163 124 41%
Self-management of Oral Anticoagulation 2014 2 35 83%
American Heart Association American College of Cardiology - Foundation guide to warfarin therapy 2003 156 177 34%
International normalized ratios (INR): the first 20 years 2004 51 64 91%
Self-testing and self-management of oral anticoagulation therapy in children 2011 7 38 79%
Patient self-testing and self-management of oral anticoagulation 2009 10 49 94%
Computerized clinical decision support systems for therapeutic drug monitoring and dosing: A decision-maker-researcher partnership systematic review 2011 19 43 37%
Anticoagulation Patient Self-Monitoring in the United States: Considerations for Clinical Practice Adoption 2011 6 68 69%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ECAA CENT IL 33 100% 0.9% 13
2 ECAA 26 100% 0.8% 11
3 EAA CENT IL 23 100% 0.7% 10
4 HAEMOSTASIS THROMBOSIS 6 13% 3.1% 45
5 POST CARDIOL TRAINING PROGRAM 6 80% 0.3% 4
6 COMMUNITY POINT OF CARE SERV 4 75% 0.2% 3
7 EUROPEAN ACT ANTICOAGULAT EAA CENT IL 4 75% 0.2% 3
8 COOPERAT STUDIES PROGRAM COORDINATING 151K 3 57% 0.3% 4
9 SERV CENT IMMUNOHEMATOL 3 100% 0.2% 3
10 THROMBOSIS SERV LEIDEN 3 100% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000218094 PROTHROMBIN COMPLEX CONCENTRATE//PROTHROMBIN COMPLEX CONCENTRATES//ANTICOAGULATION REVERSAL
2 0.0000167030 CYP2C9//VKORC1//WARFARIN
3 0.0000157580 ATRIAL FIBRILLATION//WARFARIN//CITY HOSP
4 0.0000133257 ACTIVATED PARTIAL THROMBOPLASTIN TIMES//BLUMEA RIPARIA//INTRATHECAL FIBRINOLYSIS
5 0.0000074223 LOW MOLECULAR WEIGHT HEPARIN//UNFRACTIONATED HEPARIN//ANTI XA ACTIVITY
6 0.0000058932 PREANALYTICAL VARIABILITY//TOTAL TESTING PROCESS//LABORATORY ERRORS
7 0.0000055727 HEPARIN RESISTANCE//ACTIVATED CLOTTING TIME//ACTIVATED COAGULATION TIME
8 0.0000054763 BRIDGING ANTICOAGULATION//BRIDGING THERAPY//BLOOD THINNERS
9 0.0000052977 RIVAROXABAN//DABIGATRAN//APIXABAN
10 0.0000043626 RESIDUAL THROMBOSIS//RECURRENT VENOUS THROMBOEMBOLISM//ANTICOAGULANT RELATED BLEEDING